We are excited to announce an important evolution in Trince’s leadership structure as we enter a new phase of accelerated growth and global expansion.

Transfection is frequently performed in stem cells and cancer cell lines to explore pluripotency, unravel mechanisms of early embryonic development, and facilitate in vivo tracking of specific stem cells and their progeny.

This strategic partnership will significantly bolster our presence in Japan, a global hub for stem cell research and therapies, particularly iPSCs.

Trince, a spin-off from Ghent University, has won the prestigious Nature Spinoff Prize from the scientific journal Nature.

Ziektes behandelen met fotoporatie: ‘Je wilt iets in de cel brengen, maar die tegelijkertijd zo gezond mogelijk achterlaten’

Tuesday, June 25, 2024 – Trince, an innovative spin-off from Ghent University, is one of four finalists for the global Spinoff Prize from the scientific journal Nature.

We’re excited to announce that Trince will be attending the ISCT Conference in Dublin.

We’re pleased to share that Trince will be attending ELRIG Cell-Based Assays Conference in Göteborg.

We’re pleased to share that Trince will be attending SLAS Europe Conference in Vienna.

Join us at Drug Discovery USA 2026, the first ELRIG conference in the United States, taking place 16–17 June 2026 at Pfizer Boston, MA.

The ISSCR 2026 Annual Meeting will take place 8–11 July 2026 at the Palais des congrès de Montréal in Montréal, Canada.

The European Society of Gene & Cell Therapy (ESGCT) champions breakthrough research in gene therapy, cell therapy, and genetic vaccines.

ELRIG’s Drug Discovery 2025 is again hosted by the city of Liverpool.

The world’s best and brightest in stem cell research and regenerative medicine convene once a year for the ISSCR Annual Meeting, and you are invited!

The Annual Meeting provides an international forum where the latest gene and cell therapy developments are presented and critically discussed.